119 related articles for article (PubMed ID: 30081309)
1. Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV).
Meier K; Jaguva Vasudevan AA; Zhang Z; Bähr A; Kochs G; Häussinger D; Münk C
Virology; 2018 Oct; 523():52-63. PubMed ID: 30081309
[TBL] [Abstract][Full Text] [Related]
2. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
Ji S; Na L; Ren H; Wang Y; Wang X
J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
[TBL] [Abstract][Full Text] [Related]
3. MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation.
Betancor G; Bangham M; Jeon JK; Shah K; Lynham S; Jimenez-Guardeño JM; Malim MH
mBio; 2022 Aug; 13(4):e0171422. PubMed ID: 35880880
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors.
O'Rourke JP; Newbound GC; Kohn DB; Olsen JC; Bunnell BA
J Virol; 2002 Feb; 76(3):1510-5. PubMed ID: 11773424
[TBL] [Abstract][Full Text] [Related]
5. Host cell restriction factors of equine infectious anemia virus.
Wang XF; Zhang X; Ma W; Li J; Wang X
Virol Sin; 2023 Aug; 38(4):485-496. PubMed ID: 37419416
[TBL] [Abstract][Full Text] [Related]
6. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.
Tang YD; Na L; Zhu CH; Shen N; Yang F; Fu XQ; Wang YH; Fu LH; Wang JY; Lin YZ; Wang XF; Wang X; Zhou JH; Li CY
J Virol; 2014 Nov; 88(21):12296-310. PubMed ID: 25122784
[TBL] [Abstract][Full Text] [Related]
7. Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.
Bogerd HP; Tallmadge RL; Oaks JL; Carpenter S; Cullen BR
J Virol; 2008 Dec; 82(23):11889-901. PubMed ID: 18818324
[TBL] [Abstract][Full Text] [Related]
8. Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection.
Du C; Ma J; Liu Q; Li YF; He XJ; Lin YZ; Wang XF; Meng QW; Wang X; Zhou JH
Retrovirology; 2015 Apr; 12():36. PubMed ID: 25928027
[TBL] [Abstract][Full Text] [Related]
9. Covalent conjugation of the equine infectious anemia virus Gag with SUMO.
Wang J; Wen S; Zhao R; Qi J; Liu Z; Li W; An J; Wood C; Wang Y
Biochem Biophys Res Commun; 2017 May; 486(3):712-719. PubMed ID: 28342872
[TBL] [Abstract][Full Text] [Related]
10. Monocyte maturation controls expression of equine infectious anemia virus.
Maury W
J Virol; 1994 Oct; 68(10):6270-9. PubMed ID: 8083967
[TBL] [Abstract][Full Text] [Related]
11. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
12. Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction.
Borroto-Esoda K; Boone LR
J Virol; 1991 Apr; 65(4):1952-9. PubMed ID: 1705993
[TBL] [Abstract][Full Text] [Related]
13. Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus.
Powell DJ; Bur D; Wlodawer A; Gustchina A; Payne SL; Dunn BM; Kay J
Eur J Biochem; 1996 Oct; 241(2):664-74. PubMed ID: 8917470
[TBL] [Abstract][Full Text] [Related]
14. A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV.
OhAinle M; Helms L; Vermeire J; Roesch F; Humes D; Basom R; Delrow JJ; Overbaugh J; Emerman M
Elife; 2018 Dec; 7():. PubMed ID: 30520725
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Equine Infectious Anemia Virus Integration in the Horse Genome.
Liu Q; Wang XF; Ma J; He XJ; Wang XJ; Zhou JH
Viruses; 2015 Jun; 7(6):3241-60. PubMed ID: 26102582
[TBL] [Abstract][Full Text] [Related]
16. Cell specificity of the transcription-factor repertoire used by a lentivirus: motifs important for expression of equine infectious anemia virus in nonmonocytic cells.
Maury W; Bradley S; Wright B; Hines R
Virology; 2000 Feb; 267(2):267-78. PubMed ID: 10662622
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies
Wang XF; Liu Q; Wang YH; Wang S; Chen J; Lin YZ; Ma J; Zhou JH; Wang X
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386282
[TBL] [Abstract][Full Text] [Related]
18. Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays.
Jin J; Sturgeon T; Chen C; Watkins SC; Weisz OA; Montelaro RC
J Virol; 2007 Oct; 81(20):11226-35. PubMed ID: 17686839
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositides direct equine infectious anemia virus gag trafficking and release.
Fernandes F; Chen K; Ehrlich LS; Jin J; Chen MH; Medina GN; Symons M; Montelaro R; Donaldson J; Tjandra N; Carter CA
Traffic; 2011 Apr; 12(4):438-51. PubMed ID: 21176037
[TBL] [Abstract][Full Text] [Related]
20. Replication of equine infectious anemia virus in engineered mouse NIH 3T3 cells.
Zhang B; Montelaro RC
J Virol; 2009 Feb; 83(4):2034-7. PubMed ID: 19073738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
